MannKind Corp. (MNKD)
3.80
-0.15
(-3.80%)
USD |
NASDAQ |
Oct 02, 16:00
3.80
0.00 (0.00%)
After-Hours: 20:00
MannKind Max Drawdown (5Y) : 69.35% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 69.35% |
| August 31, 2026 | 69.35% |
| July 31, 2026 | 69.35% |
| June 30, 2026 | 69.35% |
| May 31, 2026 | 69.35% |
| April 30, 2026 | 69.35% |
| March 31, 2026 | 69.35% |
| February 28, 2026 | 68.70% |
| January 31, 2026 | 68.70% |
| December 31, 2025 | 70.93% |
| November 30, 2025 | 74.63% |
| October 31, 2025 | 86.06% |
| September 30, 2025 | 90.53% |
| August 31, 2025 | 91.94% |
| July 31, 2025 | 92.62% |
| June 30, 2025 | 94.45% |
| May 31, 2025 | 96.18% |
| April 30, 2025 | 96.71% |
| March 31, 2025 | 97.40% |
| February 28, 2025 | 97.67% |
| January 31, 2025 | 97.67% |
| December 31, 2024 | 97.67% |
| November 30, 2024 | 97.67% |
| October 31, 2024 | 97.67% |
| September 30, 2024 | 97.67% |
| Date | Value |
|---|---|
| August 31, 2024 | 97.67% |
| July 31, 2024 | 97.67% |
| June 30, 2024 | 97.87% |
| May 31, 2024 | 98.01% |
| April 30, 2024 | 98.01% |
| March 31, 2024 | 98.01% |
| February 29, 2024 | 98.01% |
| January 31, 2024 | 98.01% |
| December 31, 2023 | 98.07% |
| November 30, 2023 | 98.14% |
| October 31, 2023 | 98.14% |
| September 30, 2023 | 98.14% |
| August 31, 2023 | 98.14% |
| July 31, 2023 | 98.16% |
| June 30, 2023 | 98.16% |
| May 31, 2023 | 98.16% |
| April 30, 2023 | 98.16% |
| March 31, 2023 | 98.16% |
| February 28, 2023 | 98.16% |
| January 31, 2023 | 98.16% |
| December 31, 2022 | 98.16% |
| November 30, 2022 | 98.16% |
| October 31, 2022 | 98.16% |
| September 30, 2022 | 98.16% |
| August 31, 2022 | 98.16% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| United Therapeutics Corp. | 33.00% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Gilead Sciences, Inc. | 26.58% |
| Vertex Pharmaceuticals, Inc. | 41.60% |
| Ocugen, Inc. | 99.77% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -16.81 |
| Beta (5Y) | 1.086 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 56.59% |
| Historical Sharpe Ratio (5Y) | -0.1051 |
| Historical Sortino (5Y) | -0.1789 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.58% |